AdaptHealth
AHCO
22 hedge funds and large institutions have $110M invested in AdaptHealth in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and closing their positions.
600% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 1
69% more funds holding
Funds holding: 13 → 22 (+9)
50% more capital invested
Capital invested by funds: $73.2M → $110M (+$36.4M)
11.87% more ownership
Funds ownership: 24.41% → 36.28% (+12%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
+$19.4M |
| 2 |
AIMCA
Alberta Investment Management Corp (AIMCo)
Edmonton,
Alberta, Canada
|
+$7.28M |
| 3 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
+$5.36M |
| 4 |
FTCM
Fir Tree Capital Management
New York
|
+$4.85M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$2.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
AQR Arbitrage
Greenwich,
Connecticut
|
-$10.7M |
AHCO Hedge Fund Activity: Q3 2018 in Review
22 of the 4,375 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q3 2018, worth a combined $110M — up 50% from $73.2M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new AHCO positions and 0 closed out — a net gain of 9 holders — while 7 added to existing stakes and 1 trimmed.
The largest buyer was Highbridge Capital Management, opening a new position worth an estimated $19.4M. The largest seller was AQR Arbitrage, cutting an estimated $10.7M.
- 22 institutional investors held AdaptHealth (AHCO) as of Q3 2018, up from 13 in Q2 2018.
- Funds reported $110M of AdaptHealth stock for Q3 2018, up 50% quarter-over-quarter.
- 9 funds opened new AdaptHealth positions in Q3 2018 and 0 closed out, a net change of +9 holders.
- The largest AdaptHealth buyer in Q3 2018 was Highbridge Capital Management, an estimated $19.4M added.
- The largest AdaptHealth seller in Q3 2018 was AQR Arbitrage, an estimated $10.7M sold.
Based on aggregated 13F filings for Q3 2018.